Interestingly, gene SLC51A was up-regulated, while gene SLC51B was about 2-fold down-regulated in EC versus control tissue from patient with FIGO stage IA, low-grade tumour and tumour with ≤50% invasion into myometrium, which may affect the levels of the active OST heterodimer. The gene discussed is SLC51B; the disease is neoplasm.